Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Poor sleep is linked to a higher risk of developing and worsening urinary problems in men.

Stopping alpha-blocker medication after 6-9 months is safe and effective for most patients with bladder outlet obstruction.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Finasteride does not prevent bladder cancer.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Saw palmetto helps with nighttime urination and urine flow, similar to finasteride.

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

WS PRO 160 I 120 mg effectively treats urinary symptoms from BPH with good safety and tolerability.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

Combination therapy for 9+ months maintains symptom improvements after stopping alpha-blockers or finasteride.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Tadalafil is effective for treating urinary symptoms in men with BPH.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Using 5α-reductase inhibitors for hair loss can cause lasting sexual, physical, mental, and vascular health issues in men, even after stopping the medication.

Topical minoxidil 1% and 2% are twice as effective as placebo for female pattern hair loss.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.